Old Web
English
Sign In
Acemap
>
authorDetail
>
Tetsuhi Inada
Tetsuhi Inada
Cancer research
Medicine
Pathology
in patient
Antagonist
2
Papers
123
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A phase I first-in-human study of PRI-724 in patients (pts) with advanced solid tumors.
2017
Journal of Clinical Oncology
Anthony B. El-Khoueiry
Yan Ning
Dongyun Yang
S. Cole
Michael Kahn
Marwan Zoghbi
Jennifer Berg
Masamoto Fujimori
Tetsuhi Inada
Hiroyuki Kouji
Heinz-Josef Lenz
Show All
Source
Cite
Save
Citations (78)
A phase Ib dose-escalation study of PRI-724, a CBP/beta-catenin modulator, plus gemcitabine (GEM) in patients with advanced pancreatic adenocarcinoma (APC) as second-line therapy after FOLFIRINOX or FOLFOX.
2015
Journal of Clinical Oncology
Robert R. McWilliams
Andrew H. Ko
E. Gabriela Chiorean
Eunice L. Kwak
Heinz-Josef Lenz
Paul Nadler
Debra Wood
Masamoto Fujimori
Kohei Morita
Tetsuhi Inada
Hiroyuki Kouji
Show All
Source
Cite
Save
Citations (45)
1